Real-World Outcomes and Predictors of Response to Lu-PSMA-617 Therapy in Metastatic Castration Resistant Prostate Cancer (mCRPC): A Multicentric Study from India (ESMO Asia 2026) - Oct 1, 2026 - Abstract #762P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Clinical • Metastases • Real-world • Real-world evidence • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|
|
Inimerla Bhavya; Sudatta Roy; MV Chandrakanth; Vivek Agarwala; Sarthak Rout; S V Saju; Chidambaram N B; Honey S. Raju; Krishna Kumar Rathnam; Saphalta Baghmar; Meghana Prabhu; Sibu Jacob; Ashwin O. Philips; Lalatendu Moharana; Lipsita Samantaray; Adya K. Panda; Satya Sundar G. Mohapatra; Subhashree Dash; Suren Kumar Das; Soumya Surath Panda
|